Comparison of modified Cherney incision and vertical midline incision for management of early stage cervical cancer.

Abstract:

OBJECTIVE:The aim of this study was to compare operative feasibility and surgical outcome of the modified Cherney incision and vertical midline incision in patients undergoing radical hysterectomy and pelvic lymphadenectomy. METHODS:Between March 2005 and December 2007, retrospective data of 78 patients (n=17; modified Cherney incision, n=61; vertical midline incision) with early stage cervical cancer who received radical hysterectomy and pelvic lymphadenectomy were reviewed. RESULTS:Baseline characteristics of patients who underwent modified Cherney incision and vertical midline incision were similar except for age (mean+/-SD: 32.3+/-3.4 yr vs. 52.5+/-8.4 yr, p<0.001). Patients who received modified Cherney incision had earlier initiation of soft diet (mean+/-SD: 46.5+/-19.5 hr vs. 56.4+/-25.4 hr, p<0.016) and shorter hospital stay compared to those who received vertical midline incision (mean+/-SD: 18.0+/-4.8 days vs. 21.7+/-3.7 days, p<0.042). There was no difference in the number of dissected pelvic lymph nodes, hemoglobin change, postoperative pain, postoperative ileus, Foley indwelling duration, and perioperative complications. CONCLUSION:Excluding the selection bias for age, there was no significant difference of the clinical outcome between the modified Cherney incision group and the vertical midline incision group. Modified Cherney incision can be cosmetically performed in young age women obtaining equal number of lymph nodes without increased operative morbidity compared to vertical midline incision.

journal_name

J Gynecol Oncol

authors

Lee SH,Yim GW,Lee DW,Kim SW,Kim S,Kim JW,Kim YT

doi

10.3802/jgo.2008.19.4.246

subject

Has Abstract

pub_date

2008-12-01 00:00:00

pages

246-50

issue

4

eissn

2005-0380

issn

2005-0399

journal_volume

19

pub_type

杂志文章
  • Sonographic diagnosis and Endo-SPONGE assisted vacuum therapy of anastomotic leakage following posterior pelvic exenteration for ovarian cancer without using a protective stoma.

    abstract::Anastomotic leakage is a very significant complication after posterior pelvic exenteration and a major cause of postoperative morbidity and mortality. We present a patient who underwent an optimal debulking surgery for an advanced stage ovarian cancer (FIGO IIIC). On postoperative day 12, transvaginal ultrasound revea...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2011.22.2.131

    authors: Einenkel J,Holler B,Hoffmeister A

    更新日期:2011-06-30 00:00:00

  • Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients.

    abstract:OBJECTIVE:Our previous study showed that insulin resistance (IR) was related to endometrial hyperplasia as well as endometrial cancer. But the exact impact of IR on fertility-sparing treatment in endometrial hyperplasic disease is unclear. This study investigated how IR affects fertility-sparing treatment in endometria...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2018.29.e35

    authors: Yang B,Xie L,Zhang H,Zhu Q,Du Y,Luo X,Chen X

    更新日期:2018-05-01 00:00:00

  • DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.

    abstract:OBJECTIVE:DNA methylation has been shown to be a potential biomarker for early cancer detection. The aim of this study was to evaluate DNA methylation profiles according to liquid-based Pap (LBP) test results and to assess their diagnostic value in a Korean population. METHODS:A total of 205 patients with various Papa...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2016.27.e14

    authors: Kim MK,Lee IH,Lee KH,Lee YK,So KA,Hong SR,Hwang CS,Kee MK,Rhee JE,Kang C,Hur SY,Park JS,Kim TJ

    更新日期:2016-03-01 00:00:00

  • Gynecologic oncology group trials in uterine corpus malignancies: recent progress.

    abstract::The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced e...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2008.19.4.218

    authors: Miller DS,King LP

    更新日期:2008-12-01 00:00:00

  • Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix.

    abstract:OBJECTIVE:To compare plasma protein expression between patients with squamous cell carcinoma (SCC) of the cervix and normal controls. METHODS:Plasma samples from patients with benign gynecological disease (normal cervix, n=6) and cervical cancer (SCC, n=6) were subjected to plasma proteomic analysis using two dimensio...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2008.19.3.173

    authors: Jeong DH,Kim HK,Prince AE,Lee DS,Kim YN,Han J,Kim KT

    更新日期:2008-09-01 00:00:00

  • Robotic single site radical hysterectomy plus pelvic lymphadenectomy in gynecological cancers.

    abstract:OBJECTIVE:To evaluate the feasibility and the safety of robotic single-site radical hysterectomy (RSSRH) plus pelvic lymphadenectomy (PL) in endometrial or cervical cancer. METHODS:Patients with endometrial cancer (EC) International Federation of Gynecology and Obstetrics (FIGO) stage II, early cervical cancer (ECC) F...

    journal_title:Journal of gynecologic oncology

    pub_type: 临床试验,杂志文章

    doi:10.3802/jgo.2018.29.e2

    authors: Vizza E,Chiofalo B,Cutillo G,Mancini E,Baiocco E,Zampa A,Bufalo A,Corrado G

    更新日期:2018-01-01 00:00:00

  • Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers.

    abstract:OBJECTIVES:Two randomized, controlled studies comparing outcomes in patients treated with direct oral anticoagulants or low-molecular weight heparin for cancer-associated venous thromboembolism (VTE) have previously been performed. However, gynecologic cancers accounted for approximately 10% of the study populations. W...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2020.31.e10

    authors: Lee JH,Lee JH,Jo KW,Huh JW,Oh YM,Lee JS

    更新日期:2020-01-01 00:00:00

  • Reproductive factors for ovarian cancer in southern Chinese women.

    abstract:OBJECTIVE:To investigate the association between reproductive factors and the risk of ovarian cancer among southern Chinese women. METHODS:A hospital-based case-control study was undertaken in Guangzhou, Guangdong Province, between 2006 and 2008. A structured questionnaire was used to obtain information on parity, ora...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2013.24.2.135

    authors: Pasalich M,Su D,Binns CW,Lee AH

    更新日期:2013-04-01 00:00:00

  • p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping.

    abstract:OBJECTIVE:In cervical intraepithelial neoplasia (CIN), p16(INK4a) immunohistochemistry has been reported to be a useful diagnostic biomarker. However, limited information is available about the association between the p16(INK4a) immunohistochemistry and the outcomes of CIN. Here, we report p16(INK4a) immunohistochemist...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2013.24.3.215

    authors: Nishio S,Fujii T,Nishio H,Kameyama K,Saito M,Iwata T,Kubushiro K,Aoki D

    更新日期:2013-07-01 00:00:00

  • Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS).

    abstract::All surgery performed in an epicenter of the coronavirus disease 2019 (COVID-19) pandemic, irrespective of the known or suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) status of the patient, should be regarded as high risk and protection of the surgical team at the bedside should be at the highe...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章,评审

    doi:10.3802/jgo.2020.31.e59

    authors: Kimmig R,Verheijen RHM,Rudnicki M,for SERGS Council.

    更新日期:2020-05-01 00:00:00

  • The risk of lymphedema after postoperative radiation therapy in endometrial cancer.

    abstract:OBJECTIVE:Lower extremity lymphedema adversely affects quality of life by causing discomfort, impaired mobility and increased risk of infection. The goal of this study is to investigate factors that influence the likelihood of lymphedema in patients with endometrial cancer who undergo adjuvant radiation with or without...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2016.27.e4

    authors: Mitra D,Catalano PJ,Cimbak N,Damato AL,Muto MG,Viswanathan AN

    更新日期:2016-01-01 00:00:00

  • Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.

    abstract:OBJECTIVE:To investigate the changes of incidence and prognosis of epithelial ovarian cancer in thirty years in Taiwan. METHODS:The databases of women with epithelial ovarian cancer during the period from 1979 to 2008 were retrieved from the National Cancer Registration System of Taiwan. The incidence and prognosis of...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2013.24.4.342

    authors: Chiang YC,Chen CA,Chiang CJ,Hsu TH,Lin MC,You SL,Cheng WF,Lai MS

    更新日期:2013-10-01 00:00:00

  • Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.

    abstract:OBJECTIVE:The purpose of this study was to investigate the prognostic value of lymph node ratio (LNR) in patients with stage III ovarian high-grade serous carcinoma (HGSC). METHODS:A multicenter, retrospective department database review was performed to identify patients with ovarian HGSC at 6 gynecologic oncology cen...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2018.29.e12

    authors: Ayhan A,Ozkan NT,Sarı ME,Celik H,Dede M,Akbayır Ö,Güngördük K,Şahin H,Haberal A,Güngör T,Arvas M,Meydanlı MM

    更新日期:2018-01-01 00:00:00

  • Performance of a low cost magnifying device, Magnivisualizer, versus colposcope for detection of pre-cancer and cancerous lesions of uterine cervix.

    abstract:OBJECTIVE:To assess the performance of a low cost magnifying device (Magnivisualizer) compared to a standard optical colposcope for detection of precancerous and cancerous lesions of the uterine cervix. METHODS:A total of 659 consecutive symptomatic women attending a gynecologic outpatient clinic underwent unaided vis...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2014.25.4.282

    authors: Singh V,Parashari A,Gupta S,Sodhani P,Sehgal A

    更新日期:2014-10-01 00:00:00

  • The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix.

    abstract:OBJECTIVE:To evaluate the efficacy of modified Swede Colposcopic Index (MSCI) to predict high-grade lesion and cancer of cervix (CIN2+, cervical intraepithelial neoplasia grade 2 or worse) in women with abnormal cervical cytology who underwent a colposcopy. METHODS:We conducted a retrospective study and MSCI using 5 f...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2019.30.e78

    authors: Rodpenpear N,Pataradool K

    更新日期:2019-09-01 00:00:00

  • Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

    abstract:OBJECTIVE:The goal of this study was to investigate the relationship between plasma levels of insulin-like growth factors-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) and the risk for cervical intraepithelial neoplasia (CIN) and cervical cancer. METHODS:Plasma levels of IGF-1 and IGFBP-3 of 44 cervical cancer patient...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2010.21.3.174

    authors: Lee SW,Lee SY,Lee SR,Ju W,Kim SC

    更新日期:2010-09-01 00:00:00

  • Condom and oral contraceptive use and risk of cervical intraepithelial neoplasia in Australian women.

    abstract:OBJECTIVE:To assess the association between condom use and oral contraceptive consumption and the risk of cervical intraepithelial neoplasia (CIN). METHODS:A cross-sectional study was conducted in Perth clinics. A total of 348 women responded to the structured questionnaire. Information sought included demographic and...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章,多中心研究

    doi:10.3802/jgo.2014.25.3.183

    authors: Chih HJ,Lee AH,Colville L,Xu D,Binns CW

    更新日期:2014-07-01 00:00:00

  • Late presentation of metastatic smooth muscle neoplasm of the uterus with low malignant potential.

    abstract::A 48-year-old woman underwent total abdominal hysterectomy with conservation of the ovaries and tubes. Histology showed a well-circumscribed smooth muscle tumor with foci of degeneration (including infarct-type necrosis) but no coagulative tumor cell necrosis and only mild focal cytological atypia. She presented, 24 y...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2012.23.1.69

    authors: Canciani GN,Burbos N,Duncan TJ,Lonsdale R,Nieto JJ

    更新日期:2012-01-01 00:00:00

  • SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells.

    abstract:OBJECTIVE:As cancer stem cells (CSCs) are considered as the origin of tumor development, recurrence, and drug resistance, we aimed to explore the mechanism related to modulating stemness in CSCs, thus facilitating to search for new therapeutic strategy for ovarian cancer. METHODS:In this study, ovarian cancer stem cel...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2020.31.e46

    authors: Yue Y,Xia L,Xu S,Wang C,Wang X,Lu W,Xie X

    更新日期:2020-07-01 00:00:00

  • Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.

    abstract:OBJECTIVE:To describe metastatic pattern of uterine leiomyosarcomas (ULMS) and correlate it with clinical and histopathologic parameters. METHODS:We included 113 women (mean age, 53 years; range, 29 to 72 years) with histopathology-confirmed ULMS from 2000 to 2012. Distribution of metastases was noted from imaging by ...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2014.25.4.306

    authors: Tirumani SH,Deaver P,Shinagare AB,Tirumani H,Hornick JL,George S,Ramaiya NH

    更新日期:2014-10-01 00:00:00

  • Metastasis to the ovaries from transitional cell carcinoma of the bladder and renal pelvis: a report of two cases.

    abstract::Ovarian metastases from a primary urinary tract carcinoma are extremely rare. This can be difficult to distinguish from transitional cell carcinomas (TCC) of ovarian origin because of histologic similarity. A 65-year-old woman who was diagnosed with renal pelvis TCC 4 months prior was referred for evaluation of a left...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2010.21.1.59

    authors: Lee M,Jung YW,Kim SW,Kim SH,Kim YT

    更新日期:2010-03-01 00:00:00

  • Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report.

    abstract::Toremifene is an anti-estrogen which has been shown to be effective in the treatment of breast cancer, and is thought to be a less uterotrophic agent than tamoxifen. The risk assessment concerning endometrial cancer has been inconclusive because of its rare use up to the mid-1990s. We report a case of an adenosarcoma,...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2010.21.4.269

    authors: Chung YW,Bae HS,Han SI,Song JY,Kim IS,Kang JS

    更新日期:2010-12-30 00:00:00

  • Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study.

    abstract:OBJECTIVE:The malignant transformation (MT) of ovarian mature cystic teratoma (MCT) to squamous cell carcinoma (SCC) is very rare. This study analyzed cases from multiple medical centers in Taiwan to investigate the clinicopathologic characteristics, treatment, and prognostic factors of this disease and reviewed relate...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章,评审

    doi:10.3802/jgo.2017.28.e69

    authors: Chiang AJ,Chen MY,Weng CS,Lin H,Lu CH,Wang PH,Huang YF,Chiang YC,Yu MH,Chang CL

    更新日期:2017-09-01 00:00:00

  • Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study.

    abstract:OBJECTIVE:To evaluate survival impact of low anterior resection (LAR) in patients with epithelial ovarian cancer (EOC) grossly confined to the pelvis. METHODS:We retrospectively reviewed 397 patients who underwent primary staging surgery for treatment of 2014 International Federation of Gynecology and Obstetrics (FIGO...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2018.29.e60

    authors: Kim M,Suh DH,Park JY,Paik ES,Lee S,Eoh KJ,Nam JH,Lee YY,Kim JW,Kim S

    更新日期:2018-07-01 00:00:00

  • Neoadjuvant chemotherapy followed by fertility-sparing surgery for women with stage IB1 cervical cancer.

    abstract::Fertility-sparing surgery was optimal to patients with tumor diameter smaller than 2 cm. For patients with larger tumors, neoadjuvant chemotherapy can debulk the tumor and offer the chance of surgery. We report 2 cases of stage IB1 cervical cancer treated by neoadjuvant chemotherapy and fertility-sparing surgery. Rele...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2013.24.3.287

    authors: Wang D,Yang J,Shen K,Xiang Y

    更新日期:2013-07-01 00:00:00

  • Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.

    abstract:OBJECTIVE:To compare survival outcomes between cervical adenocarcinoma (ADC) and squamous cell carcinoma (SCC) using a propensity score matching (PSM) analysis based on the Surveillance, Epidemiology, and End Results (SEER) Program. METHODS:Patients diagnosed with cervical cancer between 1998 and 2016 were identified ...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2020.31.e80

    authors: Pan X,Yang W,Wen Z,Li F,Tong L,Tang W

    更新日期:2020-11-01 00:00:00

  • Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.

    abstract:OBJECTIVE:We aimed to assess the efficacy of neoadjuvant chemotherapy followed by surgery (NACT+S), and compared the clinical outcome with that of concurrent chemoradiotherapy (CCRT) in patients with International Federation of Gynecology and Obstetrics (FIGO) IB-IIB cervical cancer. METHODS:We reviewed 85 patients wi...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2016.27.e52

    authors: Lee J,Kim TH,Kim GE,Keum KC,Kim YB

    更新日期:2016-09-01 00:00:00

  • Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study.

    abstract:OBJECTIVE:This prospective randomized controlled pilot study aimed to find whether gelatin-thrombin matrix used as a tissue sealant (FloSeal) can prevent the occurrence of pelvic lymphocele in patients with gynecologic cancer who has undergone pelvic lymphadenectomy. METHODS:Each patient, who undergo a laparotomic pel...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章,随机对照试验

    doi:10.3802/jgo.2017.28.e37

    authors: Kim YH,Shin HJ,Ju W,Kim SC

    更新日期:2017-05-01 00:00:00

  • Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.

    abstract:OBJECTIVE:To report on the incidence of nab-paclitaxel hypersensitivity reactions (HSRs) in patients with prior taxane HSR. METHODS:From 2005 to 2015, all patients who received nab-paclitaxel for a gynecologic malignancy were identified. Chart abstraction included pathology, prior therapy, indication for nab-paclitaxe...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2017.28.e38

    authors: Maurer K,Michener C,Mahdi H,Rose PG

    更新日期:2017-07-01 00:00:00

  • Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial.

    abstract:OBJECTIVE:The standard dose for pegylated liposomal doxorubicin (PLD) is 50 mg/m² every 4 weeks. While 40 mg/m² has recently been used in clinical practice, evidence supporting this use remains lacking. METHODS:This phase III randomized, non-inferiority study compared progression-free survival (PFS) for patients with ...

    journal_title:Journal of gynecologic oncology

    pub_type: 杂志文章

    doi:10.3802/jgo.2021.32.e9

    authors: Motohashi T,Yabuno A,Michimae H,Ohishi T,Nonaka M,Takano M,Nishio S,Fujiwara H,Fujiwara K,Kondo E,Sugiyama T,Tabata T

    更新日期:2021-01-01 00:00:00